29453451

Summary
Title
Prevalence and impact of baseline resistance-associated substitutions on the efficacy of ledipasvir/sofosbuvir or simeprevir/sofosbuvir against GT1 HCV infection.
Authors
  • Wang GP
  • Terrault N
  • Reeves JD
  • Liu L
  • Li E
  • Zhao L
  • Lim JK
  • Morelli G
  • Kuo A
  • Levitsky J
  • Sherman KE
  • Frazier LM
  • Ramani A
  • Peter J
  • Akuskevich L
  • Fried MW
  • Nelson DR
Source
Sci Rep
Publication Date
2018 Feb 16
PubMed ID
29453451

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024